Valneva's Lyme disease vaccine faces final clinical test in a sparse landscape - Pharmaceutical Technology
8/17/2022 12:00:00 AM2 years 8 months ago
by Adam Zamecnik
by Adam Zamecnik
On August 8, Pfizer and Valneva announced the initiation of a Phase III study with their Lyme disease vaccine, bringing the prospect of an injection to prevent the condition disease one step closer to
On August 8, Pfizer and Valneva announced the initiation of a Phase III study with their Lyme disease vaccine, bringing the prospect of an injection to prevent the condition disease one step closer t… [+6128 chars]
full article...